Abstract
In this study, the surface of the glassy carbon electrode was modified with glutardialdehyde. The modified glassy carbon electrode showed electrocatalytic activity against ivermectin. The glassy carbon electrode modified with glutardialdehyde showed high sensitivity, selectivity, and stability in the determination of ivermectin. The peak current of glutardialdehyde oxidation obtained by differential pulse voltammetry decreased inversely with the ivermectin concentration. Ivermectin inhibited the oxidation reaction of glutardialdehyde and caused a decrease in current. This change made the analysis of ivermectin electrochemically possible. In order to demonstrate the applicability of the developed method in real samples, recovery studies were carried out in tap water and urine. The highest sensitivity (0.45 µA/((µmol·L−1)(cm2))) was achieved with urine sample and the lowest detection limit as 2.66 × 10−6 mol·L−1 was obtained with BRT solution sample.
Graphical abstract
Keywords: Ivermectin, Voltammetry, Electrochemical sensor, Glutardialdehyde, COVID-19
Introduction
The COVID-19 outbreak first appeared in the city of Wuhan, in Hubei Province of China, in early December 2019, according to the World Health Organization (WHO). By spreading to Europe, the USA, and other continents, it has deeply affected international political and economic relations as well as the world’s health system [1, 2]. In order to prevent this disease, various vaccines have been developed and vaccination processes have started rapidly. In addition, various studies have been carried out on treatment methods for patients. COVID-19 is caused by the betacoronavirus that causes pneumonia by affecting the lower respiratory tract, called SARS-CoV-2 [3]. SARS-CoV-2 is considered as a relative of Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). The betacoronavirus is a positive single-stranded RNA virus [4].
Ivermectin (IVM) is a FDA-approved broad-spectrum anti-parasitic agent, and recent studies have demonstrated antiviral effects on many RNA and DNA viruses, including SARS-CoV-2 [2, 5–9]. Based on drug safety sheet data for ivermectin (New Drug Application Identifier: 50–742/S-022), possible side effects are as follows: increase in alanine aminotransferase and aspartate aminotransferase (2%), headache (6%), dysmenorrhea (5.5%), leukocyte count decrease (3%), dizziness (3%), itching (3%), peripheral edema (3%), tachycardia (3%), nausea (2%), upper respiratory tract infection symptoms (1.8%), and diarrhea (1.8%) [10].
In addition, ivermectin, which is frequently used by cattle breeders due to its effectiveness against parasites, can accumulate in fat and muscle tissue over time due to its lipophilicity [11]. When meat obtained from cattle is consumed by humans, it is important to analyze the accumulation of ivermectin in its structure. If the ivermectin concentration in beef is higher than the maximum allowable residue limit (100 μg·kg−1), the beef is considered as contaminated and may cause embryotoxicity [12].
Various studies have been conducted on residue analyzes of ivermectin in blood plasma [13, 14] and urine [15]. For the determination of IVM, liquid chromatography–tandem mass spectrometry [14, 16–22], high-performance liquid chromatography [23–26], and amperometric methods [27] were used. Difficulties in implementation of the chromatographic methods, such as need for specialists, need for expensive devices, high solvent consumption, and the complex preprocessing treatments, made electrochemical sensor applications more attractive.
In this study, the electrochemical analysis methods which are more cost-effective, have low sensitivity, and have less solvent consumption were applied for detection of IVM residual in BRT buffer solution, in tap water, and in urine sample. Glutaraldehyde or glutardialdehyde is used as a cross-linker for electrode modification in electrochemical sensor studies [28–30] and allows the sensor material to be immobilized to the electrode surface. İpek [31] used glutaraldehyde as a sensing element for the analysis of carbaryl pesticide. Glassy carbon electrode (GCE) was modified with glutardialdehyde and GA2/GCE electrode was achieved for IVM detection.
Materials and Method
Chemicals
Electrochemical studies were performed with the Ivium pocketstat potentiostat/galvanostat impedance analyzer. During the experimental studies, ultrapure water from the Millipore direct-3QV brand device was used. pH measurements were carried out with the Ohaus starter 3000 Bench pH meter. In voltammetric studies, glassy carbon electrode (GCE, CHI104) and GCE modified with glutardialdehyde electrode (GA2/GCE) were used as working electrodes in separate measurements. Ag/AgCI (3 mol·L−1 NaCI) electrode was utilized as reference electrode (MF-2052, BASI) and as counter electrode Pt wire was used. Ivermectin (IVM, CAS no: 70288–86-7) determined during the study was obtained from Sigma-Aldrich company. The stock solution of 1 × 10−3 mol·L−1 IVM was prepared in methanol and stored at + 4 °C. Glutardialdehyde (GA2, 25%) which was used in the modification of the electrode surface was obtained from Merck company. In addition, all chemicals (sodium hydroxide (NaOH), hydrochloric acid (HCl), boric acid (H3BO3), acetic acid (CH3COOH), and phosphoric acid (H3PO4)) which were used for the Britton-Robinson buffer (BRT) solution preparation were of analytical purity and were obtained from Merck company.
Preparation of GA2/GCE Electrode
The surface of the GCE was cleaned and polished using aluminum oxide (alumina, Al2O3) with 0.05 µm particle size. Glassy carbon electrode was sonicated in an ultrasonic bath in deionized water for 10 min in order to clean the alumina residues remaining on its surface. GA2/GCE electrode was obtained as a result of dropping 5.0 µL of 5% glutardialdehyde (GA2) solution onto the cleaned electrode surface and drying it at room temperature and conditions for 2 h.
Ivermectin Analysis
Glassy carbon electrode modified with GA2 (GA2/GCE) was used as the working electrode. In order to increase the solubility of ivermectin, methanol was added to the solution medium at 25% of the volume of the buffer solution. Before adding ivermectin to the phosphate buffer, differential pulse voltammograms of the buffer were recorded. Then, voltammetric measurements were made by adding ivermectin with known concentration to the electrolytic buffer solution. The optimized operating conditions for differential pulse voltammetry (DPV) measurements of ivermectin are as follows: pH value of 12.02 for phosphate buffer as supporting electrolyte, pulse time: 10 ms, pulse amplitude: 200 mV, scan rate: 50 mV s−1, and Estep: 2 mV.
Results and Discussion
Electrode Characterization
Modified electrode surface was investigated with a stereo microscope equipped with Sony IMX485 sensor, coaxial lamp, and Nikon monocular C-Mount lens. The achieved optical images were given in Fig. 1.
Fig. 1.
GA2/GCE-modified electrode (A) GA2 film surface, (B) scratched GA2 film, (C) film cross-section, (D) film edge
A homogenous, uniform thin film with a thickness about 40 µm was observed with the microscope. After preparation of modified electrode, electrochemical measurements were applied with differential pulse voltammetry (DPV) technique. DPV images of GCE and modified GA2/GCE electrode were exhibited in Fig. 2.
Fig. 2.
DPV voltammograms of GCE and GA2/GCE electrodes in BRT solution
After a smooth and clean DPV voltammogram had been achieved with GCE electrode, it was modified with GA2. GA2/GCE electrode had two oxidation peaks at 0.9 V and 1.45 V as O1 and O2 peaks, respectively.
Determination of Working pH
Anodic behavior of 2.85 × 10−4 mol·L−1 ivermectin in BRT solution at different pH values (pH 1.99, pH 5.01, pH 7.02, pH 9.01, pH 11.02, pH 12.02) was investigated with GCE and DPV technique. The highest anodic peak current was obtained at pH 12.02, as shown in Fig. 3. Thus, pH 12.02 BRT buffer solution was used throughout the electrochemical detection studies.
Fig. 3.
Effect of pH on the peak current intensity of 2.85 × 10−4 mol·L−1 ivermectin: (a) peak current vs. pH and (b) peak potential vs. pH
Figure 3(a) shows the change in the current value of the ivermectin peak detected using GCE with the change in the hydrogen concentration of the medium. Accordingly, pH 9 was a critical value, and an increasing trend in the peak current was observed after pH 9. The maximum peak current was obtained when the pH value of the BRT solution used was 12.02. In Fig. 3(b), the changes in the peak potential simultaneously with the peak current changes are shown. The breaking point at the peak potential was observed at pH 7.02. While the peak potential decreased up to pH 7.02, the potential value increased after pH 7.02. Since the high peak current will allow the sensor to make more sensitive measurements, the pH was chosen as 12.02 for the electrochemical ivermectin sensor studies.
Detection of IVM with GA2/GCE Electrode in BRT Solution
Electrochemical behaviors of 2.85 × 10−4 mol·L−1 ivermectin were investigated using GCE and GA2/GCE electrodes separately using DPV technique. The resulting DPV voltammograms are shown in Fig. 4. The peak current obtained with the GA2/GCE electrode was sharper and more pronounced than the peak current obtained with the GCE electrode, and its intensity was 1.46 times higher. This result showed that the GA2/GCE-modified electrode was more sensitive to IVM.
Fig. 4.
Differential pulse voltammograms for glassy carbon electrode and GA2/GCE electrode in BRT (pH 12.02) solution in the presence of 2.85 × 10−4 mol·L−1 IVM
DPV is preferred more than CV because of its sensitivity and low background current [32]. Quantitative determination of IVM was applied using the DPV method and GA2/GCE modified electrode in BRT solution at pH 12.02. The DPV voltammograms and calibration curve was given in Fig. 5.
Fig. 5.
Electrochemical quantitative detection of IVM with GA2/GCE electrode in BRT solution at pH 12.02; (a) DPV technique voltammograms of different IVM concentrations and (b) peak current intensities of each concentration of IVM (calibration curve)
DPV measurements started with 0.99 µmol·L−1 concentration of IVM and gradually IVM concentration increased until reaching 444 µmol·L−1 concentration. Ten repetitive measurements were applied for each concentration of IVM in BRT solution at pH 12.02. The standard deviation of the results were calculated with these repetitive measurements. The peak potential was 1.286 V and the current intensity decreased with addition of IVM into solution. The oxidation peak was thought to be corresponding with glutardialdehyde and addition of IVM inhibited the oxidation activity of glutardialdehyde. The inhibition leads the decrease in the peak current intensity as given in Fig. 5a, b. To see this decrease and calculate the sensor properties, peak current intensities plotted against each concentration of IVM and exhibited in the inner graph as Fig. 5(b).
There was two linear concentration ranges. In the linear concentration, ranges were between 9.99 × 10−7 mol·L−1–1.1 × 10−4 mol·L−1 and 1.1 × 10−4 mol·L−1–4.41 × 10−4 mol·L−1, respectively. In both ranges, the peak current intensity of the IVM decreased linearly. Linear regression equation for the 1st operating range was I (µA) = −0.755 C (µmol·L−1) with a regression coefficient of R2 = 0.985. Linear regression equation for 2nd working range was I (µA) = −0.121 C (µmol·L−1) + 1 × 10−4 having the regression coefficient of R2 = 0.985. The limit of detection (LOD) value of the modified electrode can be calculated using Eq. 1 [33]:
| 1 |
In this equation, S is standard deviation of the measurements and m is the slope of the calibration line in the linear range. LOD was calculated to be 2.66 × 10−6 mol·L−1 for the first linear range and 3.89 × 10−5 mol·L−1 for the second linear range. Limit of quantitation (LOQ) value can be calculated using Eq. 2 [33]:
| 2 |
LOQ was found to be 8.87 × 10−6 mol·L−1 for the first linear range and 1.30 × 10−4 mol·L−1 for the second linear range. The sensor parameters of GA2/GCE electrode for IVM detection were given in Table 1.
Table 1.
Analytical parameters for the voltammetric determination of IVM by differential pulse voltammetry (DPV) in BRT (pH 12.02) solution, using GA2/GCE electrode
| Method (DPV) | 1st linear range | 2nd linear range |
|---|---|---|
| Linear working range, mol L−1 | 9.99 × 10−7–1.1 × 10−4 | 1.1 × 10−4–4.41 × 10−4 |
| Slope, A/mol L−1 | −0.755 | −0.123 |
| Regression coefficient, R2 | 0.985 | 0.945 |
| LOD, mol L−1 | 2.66 × 10−6 | 3.89 × 10−5 |
| LOQ, mol L−1 | 8.87 × 10−6 | 1.30 × 10−4 |
| Repeatability of peak potential, RSDa% (intra-day) | 0.94 | |
| Repeatability of peak potential, RSDa% (intra-day) | 0.50 | |
| Repeatability of peak current, RSDa% (intra-day) | 0.82 | |
| Repeatability of peak current, RSDa% (intra-day) | 1.12 |
Relative standard deviation, RSD%=(s÷x), an = 3
This proposed method for the determination of IVM was carried out in a shorter time than the previous chromatographic and electrochemical methods and at an affordable cost without any synthesis or pre-separation process [15, 23, 27, 34].
In order to determine the measurement repeatability of GA2/GCE, 3 separate measurements of 0.285 mM IVM were taken during the day with the same electrode. The relative standard deviation (RSD%) of this electrode was calculated as 0.82. To estimate the reproducibility of GA2/GCE, the relative standard deviations (RSD%) of the three independently prepared electrodes using solution containing 0.285 mmol·L−1 IVM were calculated as 1.12. These results showed that the measurement repeatability and reproducibility of the developed modified electrode were at desirable level.
Sensor Studies of IVM Residue in Tap Water Sample
Increasing amount of 1 × 10−3 mol·L−1 IVM solution was added into the electrolytic BRT solution and tap water. Tap water was 25% by volume of the total solution. The electrochemical activity against the GA2/GCE electrode was measured and the DPV data were recorded (Fig. 6(a)). A linear calibration plot was drawn using peak current intensities of the voltammograms (Fig. 6(b)). An excellent linearity was found between 3.98 × 10−6 mol·L−1 and 2.85 × 10−4 mol·L−1. The linear regression equation was calculated as I (µA) = − 0.445 C (µmol·L−1) and the regression coefficient was R2 = 0.990. LOD and LOQ values were calculated as 1.54 × 10−5 mol·L−1 and 5.13 × 10−5 mol·L−1, respectively.
Fig. 6.
Electrochemical quantitative detection of IVM with GA2/GCE electrode in (BRT solution + tap water) solution at pH 12.02; (a) DPV voltammograms of different IVM concentrations and (b) peak current intensities of each concentration of IVM (calibration curve)
In order to determine the feasibility of this method, recovery studies were carried out with tap water sample. Achieved data were shown in Table 2.
Table 2.
Determination and recovery % of IVM in tap water (number of experiments; n = 3)
| IVM added (mg) | Found (mg) | Recovery (%) |
|---|---|---|
| 0.7 | 0.726638 | 103.7935 |
| 0.7 | 0.706752 | 100.953 |
| 0.7 | 0.736984 | 105.2713 |
These results showed that the method for the determination of IVM with GA2/GCE can also be applied to real samples.
Sensor Studies of IVM Residue in Urine Sample
Canga et al. [5] reported in their review article that only 1% of ivermectin and its metabolites were removed via urine from the body. The urine sample taken from a healthy individual was added to the BRT (pH 12.02) solution, constituting 25% of the total electrolytic solution by volume, and the stock IVM solution (1 × 10−3 mol·L−1) was gradually added to the resulting electrolyte solution and the DPV data were recorded (Fig. 7(a)). A linear calibration plot was drawn using the recorded voltammograms (Fig. 7(b)) and an excellent linearity was found between 3.98 × 10−6 mol·L−1 and 1.667 × 10−4 mol·L−1. The linear equation of the calibration line was calculated as I (µA) = −0.032 C (µmol·L−1) + 1.0 × 10−5 and the regression coefficient of calibration line was R2 = 0.998. The LOD and LOQ values were calculated as 1.94 × 10−5 mol·L−1 and 6.46 × 10−5 mol·L−1, respectively.
Fig. 7.
Electrochemical quantitative detection of IVM with GA2/GCE electrode in (BRT solution + urine) solution at pH 12.02; (a) DPV voltammograms of different IVM concentrations and (b) peak current intensities of each concentration of IVM (calibration curve)
Recovery calculations were made to show the applicability of this method. Recovery rates were shown in Table 3.
Table 3.
Determination and recovery % of IVM in urine (number of experiments; n = 3)
| IVM added (mg) | Found (mg) | Recovery (%) |
|---|---|---|
| 0.0875 | 0.0540 | 61.76066 |
| 0.0875 | 0.0552 | 63.11841 |
| 0.0875 | 0.0522 | 59.74093 |
As a summary, LOD, LOQ, linear detection ranges, and sensitivity parameters of GA2/GCE-modified electrode were given in Table 4. While the highest sensitivity (0.45 µA/((µmol·L−1)(cm2))) was achieved with urine sample, the lowest detection limit as 2.66 × 10−6 mol·L−1 was obtained with BRT solution sample. Since it has a high sensitivity in urine sample that consists of different materials having interference effect, it can be concluded that the selectivity of the electrode was in desired level. Excellent selectivity and sensitivity properties of GA2/GCE-modified electrode make it a simple and low-cost sensor of IVM for water and urine samples.
Table 4.
Sensor parameter of GA2/GCE for IVM determination in different samples
| Sample | LOD [mol·L−1] | LOQ [mol·L−1] | Linear range [mol·L−1] | Sensitivity [µA/((µ mol·L−1)(cm2))] | Recovery % | ||||
|---|---|---|---|---|---|---|---|---|---|
| LR1 | LR2 | LR1 | LR2 | LR1 | LR2 | LR1 | LR2 | ||
| BRT solution | 2.66 × 10−6 | 3.89 × 10−5 | 8.87 × 10−6 | 1.30 × 10−4 | 9.99 × 10−7–1.1 × 10−4 | 1.1 × 10−4–4.41 × 10−4 | 10.69 | 1.71 | 100 |
| BRT solution + tap water | 1.54 × 10−5 | – | 5.13 × 10−5 | – | 3.98 × 10−6–2.85 × 10−4 | – | 6.30 | – | 103.34 |
| BRT solution + urine | 1.94 × 10−5 | – | 6.46 × 10−5 | – | 3.98 × 10−6–1.667 × 10−4 | – | 0.45 | – | 61.54 |
LR, linear range.
Conclusions
In this study, GA2/GCE-modified electrode was used for the determination of IVM. Compared with GCE and GA2/GCE, the higher peak current of IVM in the modified electrode showed that the modified electrode was more suitable for detection. The value of this study is that the electrode surface is modified without the need for any synthesis process and it allows rapid, sensitive, and selective determination of IVM at low concentrations. The modified electrode showed both good repeatability and stability. With the proposed method, recovery studies were carried out on real samples (tap water and urine) using the direct calibration graph method. The highest sensitivity (0.45 µA/((µmol·L−1)(cm2))) was achieved with urine sample and the lowest detection limit as 2.66 × 10−6 mol·L−1 was obtained with BRT solution sample. Although the GA2/GCE electrode sensitivity was high with urine sample, its recovery % average was 61.54. The interference effect of the other metabolites consisted in the urine prevented detection with 100% recovery ratio. Thus, it can be said that the selectivity of the electrode was lower for urine sample.
In further studies, ivermectin analysis in milk sample can be studied. In a study by Ogbuokiri et al. [35], when a healthy mother used ivermectin at a dosage of 150 μg/kg, ivermectin concentration in breast milk was measured as 14.1 ng·mL−1 6.5 h later. Therefore, it will help mothers who have to use the ivermectin for medical purposes to measure the ivermectin residue in breast milk rapidly, sensitively, and selectively to choose the appropriate time to feed their babies.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Berna Koçak, Email: bernakocak@munzur.edu.tr.
Yeliz İpek, Email: yelizipek@munzur.edu.tr.
References
- 1.V.M. Corman, O. Landt, M. Kaiser, R. Molenkamp, A. Meijer, D.K.W. Chu, T. Bleicker, S. Brünink, J. Schneider, M.L. Schmidt, D.G.J.C. Mulders, B.L. Haagmans, B. van der Veer, S. van den Brink, L. Wijsman, G. Goderski, J.-L. Romette, Ellis Joanna, M. Zambon, M. Peiris, H. Goossens, C. Reusken, M.P.G. Koopmans, C. Drosten, Eurosurveillance 25(3), 2000045 (2020)
- 2.Heidary F, Gharebaghi R. J. Antibiot. 2020;73(9):593. doi: 10.1038/s41429-020-0336-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. Int. J. Surg. 2020;76:71. doi: 10.1016/j.ijsu.2020.02.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Y. İpek, Ö. Ertekin, Detection Methods and Novel Sensor Studies for Corona Virus, Editor: İrkin Reyhan, Edition: 1, Chapter 18, ISBN:978–625–7884–57–0 (Gece Kitaplığı, Ankara), pp. 287‒303 (2020)
- 5.Canga AG, Prieto AMS, Liébana MJD, Martínez NF, Vega MS, Vieitez JJG. AAPS J. 2008;10(1):42. doi: 10.1208/s12248-007-9000-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.L. Caly, J.D. Druce, M.G. Catton, D.A. Jans, K.M. Wagstaff, Antiviral Res. 104787 (2020) [DOI] [PMC free article] [PubMed]
- 7.Barrows NJ, Campos RK, Powell ST, et al. Cell Host Microbe. 2016;20:259. doi: 10.1016/j.chom.2016.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Wagstaff KM, Sivakumaran H, Heaton SM, Harrich D, Jans DA. Biochem J. 2012;443:851. doi: 10.1042/BJ20120150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wang X, Lv C, Ji X, Wang B, Qiu L, Yang Z. Virus Res. 2019;263:80. doi: 10.1016/j.virusres.2019.01.010. [DOI] [PubMed] [Google Scholar]
- 10.Munoz J, Ballester MR, Antonijoan RM, Gich I, Rodríguez M, Colli E, Gold S, Krolewiecki AJ. PLoS Negl Trop Dis. 2018;12(1):e0006020. doi: 10.1371/journal.pntd.0006020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bassissi MF, Alvinerie M, Lespine A. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2004;138:437. doi: 10.1016/j.cca.2004.07.011. [DOI] [PubMed] [Google Scholar]
- 12.Wang H, Wang Z, Liu S, Liu Z. Bull. Environ. Contam. Toxicol. 2009;82:395. doi: 10.1007/s00128-009-9638-3. [DOI] [PubMed] [Google Scholar]
- 13.Na-Bangchang K, Banmairuroi V. South East Asian Journal of Tropical Medicine and Public. Health. 2006;37(5):848. [PubMed] [Google Scholar]
- 14.Kitzman D, Wei SY, Fleckenstein L. J Pharm Biomed Anal. 2006;40(4):1013. doi: 10.1016/j.jpba.2005.08.026. [DOI] [PubMed] [Google Scholar]
- 15.M.H. Mahnashi, A.M. Mahmoud, S.A. Alkahtani, M.M. El-Wekil, Journal of Alloys and Compounds. 871, 159627 (2021)
- 16.J. Mi, R. Zhang, F. Wang, H. Xu, B. Ge, J. He, ... & B. Quarantine, Physical Testing and Chemical Analysis (Part B: Chemical Analysis). 09, (2017)
- 17.Löffler D, Ternes TA. J. Chromatogr. A. 2003;1021(1–2):133. doi: 10.1016/j.chroma.2003.08.089. [DOI] [PubMed] [Google Scholar]
- 18.Yoshii K, Kaihara A, Tsumura Y, Ishimitsu S, Tonogai Y. J. Chromatogr. A. 2000;896(1–2):75. doi: 10.1016/S0021-9673(00)00466-0. [DOI] [PubMed] [Google Scholar]
- 19.Croubels S, De Baere S, Cherlet M, De Backer P. J. Mass Spectrom. 2002;37(8):840. doi: 10.1002/jms.343. [DOI] [PubMed] [Google Scholar]
- 20.Huang JX, Lu DH, Wan K, Wang FH. Chin. Chem. Lett. 2014;25(4):635. doi: 10.1016/j.cclet.2014.01.036. [DOI] [Google Scholar]
- 21.Sheridan R, Desjardins L. J. AOAC Int. 2006;89(4):1088. doi: 10.1093/jaoac/89.4.1088. [DOI] [PubMed] [Google Scholar]
- 22.Morbidelli E, Rambaldi J, Bitti LR, Zaghini A, Barbarossa A. MethodsX. 2018;5:1503. doi: 10.1016/j.mex.2018.11.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.N.S. Rashed, S. Zayed, A. Abdelazeem, F. Fouad, Microchemical Journal 105069 (2020)
- 24.Jabber D, Norian R, Jalilvand M. Medical Laboratory Journal. 2017;11(2):16. [Google Scholar]
- 25.Krishna DR, Klotz U. Arzneimittelforschung. 1993;43(5):609. [PubMed] [Google Scholar]
- 26.P.C. Tway, Jr J.S. Wood, G.V. Downing, Journal of Agricultural and Food Chemistry 29(5), 1059 (1981) [DOI] [PubMed]
- 27.Lourencao BC, Medeiros RA, Thomasi SS, Ferreira AG, Rocha-Filho RC, Fatibello-Filho O. Sens. Actuators, B Chem. 2016;222:181. doi: 10.1016/j.snb.2015.08.036. [DOI] [Google Scholar]
- 28.Wang Z, Jia Y. Carbon. 2018;130:758. doi: 10.1016/j.carbon.2018.01.078. [DOI] [Google Scholar]
- 29.Hulupi M, Haryadi H. Materials Today: Proceedings. 2019;13(1):199. doi: 10.1016/j.matpr.2019.03.214. [DOI] [Google Scholar]
- 30.Kumar THV, Sundramoorthy AK. Anal. Chim. Acta. 2019;1074:131. doi: 10.1016/j.aca.2019.05.011. [DOI] [PubMed] [Google Scholar]
- 31.Y. İpek, J. Indian Chem. Soc. 97(A-11), 2218 (2020).
- 32.Yola ML, Atar N. Microchem. J. 2021;170:106643. doi: 10.1016/j.microc.2021.106643. [DOI] [Google Scholar]
- 33.Purushothama HT, Nayaka YA, Vinay MM, Manjunatha P, Yathisha RO, Basavarajappa KV. Journal of Science: Advanced Materials and Devices. 2018;3(2):161. [Google Scholar]
- 34.Devaka NVSK, Rao VM. Pharmaceutical Sciences. 2019;25(3):254. doi: 10.15171/PS.2019.41. [DOI] [Google Scholar]
- 35.Ogbuokiri JE, Ozumba BC, Okonkwo OP. Eur. J. Clin. Pharmacol. 1993;46:389. doi: 10.1007/BF00265962. [DOI] [PubMed] [Google Scholar]








